#1 Clinical Trials Search in Europe

Benfotiamine

Benfotiamine, a synthetic derivative of thiamine (vitamin B1), has been the subject of numerous clinical trials investigating its potential therapeutic effects in various medical conditions. This article summarizes the findings from several studies exploring benfotiamine’s efficacy in treating Alzheimer’s disease, diabetic complications, vascular dysfunction, and other health issues. By examining these trials, we aim to provide an overview of benfotiamine’s potential benefits and its role in addressing different medical challenges.

Table of Contents

What is Benfotiamine?

Benfotiamine is a special form of vitamin B1 (thiamine) that is more easily absorbed by the body compared to regular vitamin B1 supplements. It is also known by its chemical name S-benzoylthiamine O-monophoshate[1]. Benfotiamine is a fat-soluble version of thiamine, which means it can enter cells more effectively than water-soluble forms of vitamin B1[2].

Conditions Treated with Benfotiamine

Research has shown that benfotiamine may be helpful in treating or managing several health conditions, including:

  • Alzheimer’s Disease: Studies are investigating whether benfotiamine can slow down cognitive decline in patients with early Alzheimer’s disease[2].
  • Diabetic Neuropathy: This is a type of nerve damage that can occur in people with diabetes. Benfotiamine may help improve nerve function and reduce pain associated with diabetic neuropathy[3].
  • Diabetic Nephropathy: This is a kidney-related complication of diabetes. Benfotiamine is being studied for its potential to slow down the progression of kidney damage in diabetic patients[4].
  • Vascular (Blood Vessel) Health: Research suggests that benfotiamine may help improve the function of blood vessels, particularly in people with diabetes or those who smoke[5].
  • Alcohol Use Disorder: Some studies are looking at whether benfotiamine can help reduce alcohol consumption in people with drinking problems[6].

How Benfotiamine Works

Benfotiamine works in several ways to protect the body from damage caused by high blood sugar levels and other harmful substances:

  1. Increasing Thiamine Levels: Benfotiamine raises the levels of thiamine in the body more effectively than regular vitamin B1 supplements. Thiamine is important for many body functions, especially in processing sugars and producing energy[2].
  2. Blocking Harmful Pathways: It helps block several biochemical pathways that can lead to damage in the body when blood sugar levels are high. This is particularly important for people with diabetes[7].
  3. Reducing Advanced Glycation End-products (AGEs): Benfotiamine may help reduce the formation and effects of AGEs, which are harmful compounds that form when sugars react with proteins in the body. AGEs are linked to various complications in diabetes and aging[8].
  4. Improving Blood Vessel Function: Studies suggest that benfotiamine can help improve the function of the endothelium, which is the inner lining of blood vessels. This may lead to better overall vascular health[5].

Dosage and Administration

The dosage of benfotiamine can vary depending on the condition being treated and the specific study or treatment plan. Here are some examples from clinical trials:

  • For Alzheimer’s Disease: 600 mg per day (300 mg twice daily) for one year[2].
  • For Diabetic Neuropathy: 600 mg per day for the first 3 months, followed by 300 mg per day for 9 months[3].
  • For Vascular Health: 1050 mg per day for 3 days[8].
  • For Alcohol Use Disorder: 600 mg per day[6].

It’s important to note that these dosages are from research studies and may not represent standard treatment recommendations. Always consult with a healthcare provider before starting any new supplement regimen.

Potential Benefits of Benfotiamine

Research suggests that benfotiamine may offer several potential benefits:

  • Improved Cognitive Function: In Alzheimer’s disease studies, researchers are investigating whether benfotiamine can slow down cognitive decline[2].
  • Reduced Nerve Pain: For people with diabetic neuropathy, benfotiamine may help reduce pain and improve nerve function[3].
  • Better Kidney Health: In diabetic nephropathy, benfotiamine might help slow down the progression of kidney damage[4].
  • Improved Blood Vessel Function: Studies have shown that benfotiamine may help improve the function of blood vessels, which is important for overall cardiovascular health[5].
  • Reduced Alcohol Consumption: In people with alcohol use disorders, benfotiamine is being studied for its potential to help reduce drinking[6].

Ongoing Research and Future Prospects

Benfotiamine is still being actively researched for its potential benefits in various conditions. Some ongoing and recent studies include:

  • A large-scale study investigating benfotiamine’s effects on cognitive function and brain metabolism in early Alzheimer’s disease[9].
  • Research on benfotiamine’s ability to improve endothelial function (blood vessel health) in people with diabetes[7].
  • Studies exploring the use of benfotiamine in combination with other B vitamins for treating low back pain[10].

These ongoing studies may provide more information about the effectiveness and potential uses of benfotiamine in the future.

Side Effects and Safety

Benfotiamine is generally considered safe when used as directed. However, like any medication or supplement, it can potentially cause side effects. In clinical trials, researchers closely monitor participants for any adverse reactions[9].

Common side effects, if any, are usually mild and may include gastrointestinal discomfort. However, it’s important to note that long-term safety data for high doses of benfotiamine are still being collected through ongoing research.

As with any new supplement or medication, it’s crucial to consult with a healthcare provider before starting benfotiamine, especially if you have any existing health conditions or are taking other medications.

Condition Study Design Dosage Key Findings/Objectives
Alzheimer’s Disease Double-blind, placebo-controlled 600 mg/day for 1 year Aims to slow cognitive decline and improve brain glucose metabolism
Diabetic Neuropathy Double-blind, randomized, placebo-controlled 600 mg/day for 3 months, then 300 mg/day for 9 months Assessing changes in intraepidermal nerve fiber density and neuropathic symptoms
Vascular Dysfunction in Smokers Pretreatment study 1050 mg/day for 3 days Evaluating prevention of smoking-induced vascular dysfunction
Alcoholism Randomized, double-blind, placebo-controlled 600 mg/day for 6 months Assessing reduction in alcohol consumption and related problems
Diabetic Nephropathy Double-blind, placebo-controlled 900 mg/day for 12 weeks Investigating effects on urinary markers of kidney injury
Type 2 Diabetes and Endothelial Function Randomized, cross-over, double-blind 900 mg/day for 6 weeks Examining effects on fasting and postprandial endothelial function

FAQ

  • What is benfotiamine? Benfotiamine is a synthetic, fat-soluble form of thiamine (vitamin B1) that has higher bioavailability than regular thiamine. It is used in clinical trials to investigate its potential benefits in various medical conditions.
  • What conditions are being studied with benfotiamine? Clinical trials are exploring benfotiamine's potential in treating Alzheimer's disease, diabetic complications (such as neuropathy and nephropathy), vascular dysfunction, and acute non-specific low back pain.
  • How does benfotiamine work? Benfotiamine acts as a transketolase activator, directing glucose substrates to the pentose phosphate pathway. This helps block several hyperglycemia-induced pathways and may reduce the formation of advanced glycation end-products (AGEs).
  • What dosages of benfotiamine are typically used in clinical trials? Dosages vary depending on the study, but common doses range from 300 mg to 900 mg per day. Some trials use up to 1200 mg daily for specific conditions like Alzheimer's disease.
  • Are there any known side effects of benfotiamine? While benfotiamine is generally well-tolerated, some studies monitor for adverse events. As with any medication, potential side effects may occur, and patients should consult their healthcare provider for personalized information.

Ongoing Clinical Trials on Benfotiamine

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Hungary

  • Study on Thiamine for Reducing Fatigue in Rheumatoid Arthritis Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Advanced Glycation End-products (AGEs): Proteins or lipids that become glycated (bonded with sugar molecules) as a result of exposure to sugars. AGEs can contribute to the development of various diabetic complications and are associated with aging processes.
  • Endothelial Dysfunction: A condition in which the inner lining of blood vessels (endothelium) doesn't function normally, leading to reduced ability of blood vessels to dilate and increased risk of cardiovascular problems.
  • Diabetic Neuropathy: A type of nerve damage that can occur in people with diabetes, often causing pain, tingling, or loss of sensation in the extremities.
  • Diabetic Nephropathy: Kidney damage that occurs as a complication of diabetes, potentially leading to kidney failure if left untreated.
  • Flow-Mediated Dilation (FMD): A non-invasive method to assess endothelial function by measuring how blood vessels dilate in response to increased blood flow.
  • Transketolase: An enzyme involved in the pentose phosphate pathway, which is important for glucose metabolism and the production of NADPH, a molecule involved in cellular antioxidant defenses.
  • ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale, a test used to measure cognitive function in people with Alzheimer's disease.
  • Intraepidermal Nerve Fiber Density (IENFD): A measure of the number of nerve fibers in the epidermis (outer layer of skin), used to assess small fiber neuropathy.
  • Fluorodeoxyglucose Positron Emission Tomography (FDGPET): An imaging technique used to measure glucose metabolism in the brain, which can be helpful in assessing brain function in conditions like Alzheimer's disease.

References

  1. https://clinicaltrials.gov/study/NCT00117026
  2. https://clinicaltrials.gov/study/NCT02292238
  3. https://clinicaltrials.gov/study/NCT01868191
  4. https://clinicaltrials.gov/study/NCT00565318
  5. https://clinicaltrials.gov/study/NCT00785460
  6. https://clinicaltrials.gov/study/NCT00680121
  7. https://clinicaltrials.gov/study/NCT00446810
  8. https://clinicaltrials.gov/study/NCT00437008
  9. https://clinicaltrials.gov/study/NCT06223360
  10. https://clinicaltrials.gov/study/NCT03892707